Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Debility

capecitabine has been researched along with Debility in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Aparicio, T; Barbier, E; Bauguion, L; Bouché, O; Cany, L; Carola, E; Cretin, J; Desgrippes, R; Desramé, J; Etienne, PL; Falandry, C; Guérin-Meyer, V; Hiret, S; Hocine, F; Le Brun-Ly, V; Lefevre, LB; Marous, M; Martin, J; Mineur, L; Mosser, L; Reichling, C; Rinaldi, Y; Terrebonne, E; Turpin, A; Turpin, J; Van den Eynde, M1
Al-Batran, SE; de Wit, M; Dorn, J; Harbeck, N; Honecker, F; Jäger, E; Kreienberg, R; Müller, L; Otremba, B; Saupe, S; Schmidt, M; Schnabel, C; Waldenmaier, D; Warm, M; Wedding, U1
Biagi, J; Breadner, D; Cripps, C; Jonker, D; Klimo, P; Lam, W; O'Connell, A; Stitt, L; Vincent, MD; Welch, S; Whiston, F1

Trials

3 trial(s) available for capecitabine and Debility

ArticleYear
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:4

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Frailty; Humans; Leucovorin; Neoplasm Staging; Oxaliplatin

2023
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial.
    Journal of geriatric oncology, 2018, Volume: 9, Issue:2

    Topics: Age Factors; Aged; Biomarkers; Breast Neoplasms; Capecitabine; Disease Progression; Doxorubicin; Female; Frailty; Geriatric Assessment; Humans; Karnofsky Performance Status; Middle Aged; Polyethylene Glycols; Treatment Outcome

2018
Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabine.
    Journal of geriatric oncology, 2018, Volume: 9, Issue:6

    Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Frailty; Humans; Male; Quality of Life; Surveys and Questionnaires

2018